Shape Therapeutics Announces Appointment of Matt Valentino as Chief People Officer

2 years ago

SEATTLE, May 02, 2024 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a leader at the convergence of AI and RNA…

Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical Trial

2 years ago

Partnership with Leading Biotech Company Enrolls 28% of Study Participants with 22x Greater Enrollment Velocity Compared to Traditional Brick-and-Mortar Clinical…

iCAD to Report First Quarter 2024 Financial Results on May 15, 2024

2 years ago

NASHUA, N.H., May 02, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer…

Mangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq’s Minimum Stockholders’ Equity Requirement

2 years ago

Dallas, Texas, May 02, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on…

The Canadian Dermatology Association (CDA) Announces the Launch of the 2024 Shade Structure Grant Program

2 years ago

Aiming to Combat Skin Cancer with Community Shade InitiativesOTTAWA, May 02, 2024 (GLOBE NEWSWIRE) -- The Canadian Dermatology Association (CDA)…

LifeMD Becomes the First Virtual Primary Care Provider to Elevate GLP-1 Patient Care with Real-time, At-Home Monitoring of Blood Pressure and Body Composition

2 years ago

LifeMD and Withings Health Solutions partnership exemplifies the potential of digital health technology to transform virtual patient care and improve…

Lisata Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update on Thursday, May 9, 2024

2 years ago

BASKING RIDGE, N.J., May 02, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage…

Daré Bioscience Selected as a Member of ARPA-H Investor Catalyst Hub Spoke Network

2 years ago

Daré joins a nationwide network working to accelerate transformative health solutionsSAN DIEGO, May 02, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience,…

Amolyt Pharma Granted FDA Fast Track Designation for Eneboparatide for the Treatment of Hypoparathyroidism

2 years ago

Designation reflects the seriousness of the disease and the potential for eneboparatide to address the urgent need for new treatment…

PROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9

2 years ago

GARDEN CITY, NY, May 02, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), announced today that they will be…